These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 8054514)
1. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity. Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569 [TBL] [Abstract][Full Text] [Related]
3. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine). Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674 [TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice. Sharma BS; Mhaskar S; Balazs L; Siaw M Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650 [TBL] [Abstract][Full Text] [Related]
5. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression. Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135 [TBL] [Abstract][Full Text] [Related]
6. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295 [TBL] [Abstract][Full Text] [Related]
7. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. Aronson FR; Libby P; Brandon EP; Janicka MW; Mier JW J Immunol; 1988 Jul; 141(1):158-63. PubMed ID: 3259966 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF). Wright SC; Bonavida B J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908 [TBL] [Abstract][Full Text] [Related]
9. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity. Giovarelli M; Santoni A; Jemma C; Musso T; Giuffrida AM; Cavallo G; Landolfo S; Forni G J Immunol; 1988 Oct; 141(8):2831-6. PubMed ID: 3139768 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. Hanna N; Schneider M J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604 [TBL] [Abstract][Full Text] [Related]
12. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules. Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040 [TBL] [Abstract][Full Text] [Related]
13. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2. Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766 [TBL] [Abstract][Full Text] [Related]
14. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells. Lotzová E; Savary CA; Stringfellow DA J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603 [TBL] [Abstract][Full Text] [Related]
15. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets. Lebow LT; Jewett A; Bonavida B J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130 [TBL] [Abstract][Full Text] [Related]
16. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. Salazar-Mather TP; Ishikawa R; Biron CA J Immunol; 1996 Oct; 157(7):3054-64. PubMed ID: 8816415 [TBL] [Abstract][Full Text] [Related]
17. Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and E. Zhong M; Kadota Y; Shimizu Y; Gohda E Int Immunopharmacol; 2008 Mar; 8(3):508-13. PubMed ID: 18279806 [TBL] [Abstract][Full Text] [Related]
18. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma. Muralikrishna K; Varalakshmi C; Khar A Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244 [TBL] [Abstract][Full Text] [Related]
19. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent. Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity. Hafner M; Falk W; Echtenacher B; Männel DN Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]